These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2767117)

  • 41. The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 2000 Jan; 388(1):57-67. PubMed ID: 10657547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in the effects of 1-(m-trifluoromethylphenyl) piperazine and 1-(m-chlorophenyl) piperazine on copulatory behavior in the rat.
    Mendelson SD; Gorzalka BB
    Neuropharmacology; 1990 Aug; 29(8):783-6. PubMed ID: 2274113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.
    Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):605-10. PubMed ID: 1906186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol.
    Rezazadeh SM; Prather PL; Lal H
    Alcohol; 1993; 10(4):281-3. PubMed ID: 8397879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.
    Kennedy AJ; Gibson EL; O'Connell MT; Curzon G
    Psychopharmacology (Berl); 1993; 113(2):262-8. PubMed ID: 7855192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of isotheoline on mouse behavior under test conditions for detecting its anxiolytic activity].
    Zheliazkova-Savova M
    Eksp Klin Farmakol; 1998; 61(3):19-21. PubMed ID: 9690069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antiemetic drug trimethobenzamide prevents hypophagia due to acetyl salicylate, but not to 5-HT1B or 5-HT1C agonists.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):101-3. PubMed ID: 3147468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia.
    Hutson PH; Donohoe TP; Curzon G
    Psychopharmacology (Berl); 1988; 95(4):550-2. PubMed ID: 3145525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benzodiazepines impair a behavioral effect induced by stimulation of 5-HT1B receptors.
    Francès H; Khidichian F; Monier C
    Pharmacol Biochem Behav; 1990 Apr; 35(4):841-5. PubMed ID: 1971720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1989 Feb; 161(2-3):219-21. PubMed ID: 2524392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination.
    Wright FL; Rodgers RJ
    Psychopharmacology (Berl); 2014 Feb; 231(4):787-800. PubMed ID: 24114428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.